Doximity, Inc. $DOCS Shares Purchased by Quantinno Capital Management LP

Posted by on Aug 9th, 2026

Quantinno Capital Management LP increased its stake in Doximity, Inc. (NYSE:DOCS – Free Report) by 420.5% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 140,345 shares of the company’s stock after acquiring an additional 113,380 shares during the quarter. Quantinno Capital Management LP owned approximately 0.08% of Doximity worth $3,270,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in DOCS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after purchasing an additional 210 shares during the period. BOKF NA raised its position in shares of Doximity by 5.3% during the 3rd quarter. BOKF NA now owns 5,356 shares of the company’s stock worth $392,000 after purchasing an additional 269 shares during the last quarter. Northwestern Mutual Investment Management Company LLC lifted its stake in Doximity by 1.1% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 30,736 shares of the company’s stock valued at $1,361,000 after buying an additional 333 shares in the last quarter. Lifestyle Asset Management Inc. lifted its stake in Doximity by 5.9% in the 4th quarter. Lifestyle Asset Management Inc. now owns 7,083 shares of the company’s stock valued at $314,000 after buying an additional 396 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its stake in Doximity by 99.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock valued at $35,000 after buying an additional 397 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Siddharth Sitaram sold 2,444 shares of the firm’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the sale, the insider directly owned 90,706 shares of the company’s stock, valued at approximately $1,851,309.46. This trade represents a 2.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 31.80% of the company’s stock.

Wall Street Analysts Forecast Growth

DOCS has been the subject of several research reports. Robert W. Baird reiterated a “neutral” rating and set a $18.00 price objective (down from $40.00) on shares of Doximity in a research note on Thursday, May 14th. Truist Financial restated a “hold” rating and issued a $19.00 target price (down from $29.00) on shares of Doximity in a research report on Thursday, May 14th. Weiss Ratings lowered Doximity from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 15th. Piper Sandler reiterated an “overweight” rating and set a $47.00 price target (up from $42.00) on shares of Doximity in a research report on Friday. Finally, Wells Fargo & Company reissued an “equal weight” rating and issued a $18.00 price objective (down from $32.00) on shares of Doximity in a research note on Thursday, May 14th. Two analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, thirteen have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $31.86.

Get Our Latest Analysis on Doximity

Doximity News Roundup

Here are the key news stories impacting Doximity this week:

  • Positive Sentiment: Doximity reported fiscal Q1 revenue of $156.6 million, up 7.3% year over year, and adjusted earnings of $0.29 per share. Revenue exceeded expectations, while the company’s profitability and 30.4% net margin remained notable. Doximity earnings report
  • Positive Sentiment: Management raised fiscal 2027 revenue guidance to $671 million-$681 million, slightly above the analyst consensus of $670.4 million. The outlook reflects anticipated demand from pharmaceutical customers and continued adoption of Doximity’s AI capabilities. Doximity Q1 earnings and guidance
  • Positive Sentiment: The CEO said Doximity’s clinical AI search generates roughly 10 times more revenue than it costs to operate, while AI-driven engagement is outperforming expectations. Investors view this as a potential source of future monetization that is not fully reflected in current forecasts. CNBC Doximity AI report
  • Positive Sentiment: Analysts raised their targets: Piper Sandler maintained an overweight rating and lifted its target to $47 from $42, while JPMorgan raised its target to $31 from $26 but retained a neutral rating. Analyst target changes
  • Neutral Sentiment: Doximity’s addition or reclassification within the Russell 1000 may broaden institutional visibility and affect index-related trading, but it does not directly change the company’s fundamentals. Russell 1000 reclassification
  • Negative Sentiment: Adjusted earnings fell from $0.36 per share a year earlier, and some estimates showed a slight earnings miss. Higher AI investment is pressuring margins, while critics argue the rally may have moved ahead of near-term fundamentals and could reverse. Doximity rally analysis

Doximity Stock Performance

DOCS opened at $27.35 on Friday. The stock has a market capitalization of $5.00 billion, a PE ratio of 32.18, a P/E/G ratio of 9.94 and a beta of 1.29. Doximity, Inc. has a one year low of $17.15 and a one year high of $76.51. The business’s 50 day moving average price is $21.28 and its 200 day moving average price is $24.37.

Doximity (NYSE:DOCS – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.13. Doximity had a return on equity of 17.65% and a net margin of 25.48%.The company had revenue of $156.62 million during the quarter. During the same period last year, the business earned $0.36 EPS. Doximity’s revenue was up 7.3% compared to the same quarter last year. As a group, equities research analysts forecast that Doximity, Inc. will post 0.87 earnings per share for the current fiscal year.

Doximity Company Profile

(Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.

Featured Stories

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NYSE:DOCS – Free Report).

Institutional Ownership by Quarter for Doximity (NYSE:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.